In 2016 the Johnson & Johnson Partnering Office was launched to enable innovative research and development (R&D) for Queensland’s life sciences industry. The R&D facility is housed at Queensland University of Technology’s (QUT) Institute of Health and Biomedical Innovation. The R&D centre serves as a strong platform to identify and nurture life science and research collaborations. Following on from the launch in 2016, the Queensland government has now announced a significant extension of the Johnson & Johnston R&D Office at […]
The functional cosmetics brand, Cellmid Limited has received an $808,000 research and development grant under the tax incentive scheme from the Australian Taxation Office. Cellmid is an Australian life sciences accelerator with lead programs in multiple disease indications. The company holds the largest and most comprehensive portfolio of intellectual property relating to the novel targets midkine (MK) and FGF5, which are growth promoting protein supplements and products. After Cellmid generated $5.64 million in revenue for FY18 and continues to rapidly […]
Last week, the Government introduced changes to the R&D Tax Incentive as part of an Omnibus Bill, following an announcement of the changes in May’s Federal Budget. It is uncertain whether the Bill will pass both the lower house of parliament and the Senate. The revisions are proposed to apply for the 2019 Financial Year. View the first reading of the bill here.
Introduction The case Moreton Resources Ltd and Innovation and Science Australia (Taxation)  AATA 3378 refers to a mining company that registered R&D activities for the years 2012, 2013 and 2014. After an examination of the registrations, Innovation and Science Australia (ISA) determined that these activities were ineligible for the R&D Tax Incentive. The company had been subject to a number of adverse compliance reviews under the old R&D Concession, however they continued to claim. Background On 14 May 2015, […]